In January 2017, French health authorities announced that cervical cancer screening would become routine starting in 2018. As the 10th most common cancer among women in France, it's highly preventable through early detection, especially via regular Pap smears. Staying informed about the disease and its warning signs is crucial. This gynecological cancer, alongside ovarian and vaginal cancers, primarily affects postmenopausal women aged 40-74, though it can occur at any age. The UK's National Health Service (NHS) identifies risk factors including obesity, diabetes, and hormone replacement therapy (HRT) used to manage menopause symptoms.
Key warning signs include unexplained vaginal bleeding outside of menstrual periods or after menopause. Per the NHS, bleeding often starts as light spotting with watery discharge, progressively worsening. Lower abdominal pain, discomfort during intercourse, and in advanced stages, pain radiating to the back, legs, or pelvis are common. Accompanying symptoms may include loss of appetite, fatigue, and nausea. Dr. Helen Webberley emphasizes that any unexplained bleeding warrants an immediate GP consultation.
Treatment varies by cancer stage and overall health. Surgery, typically a hysterectomy removing the uterus, ovaries, and fallopian tubes, is the primary approach. Radiotherapy or chemotherapy may follow to target residual cells. Post-hysterectomy, fertility is no longer possible, but for women seeking to preserve fertility, the NHS notes hormone therapy as a limited option in select cases.
For women aged 25-65, prevention is key: follow medical guidelines with Pap smears every three years.
